Retinitis: all 248 studies
Page 2 of 3. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.
- Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem CellsCompletedNCT04224207Phase 3
- High Resolution Retina ImagingStatus unknownNCT04128150
- A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO GeneActive, not recruitingNCT04123626Phase 1/2
- Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)TerminatedNCT04120883Phase 1/2
- Minocycline Treatment in Retinitis PigmentosaCompletedNCT04068207Phase 2
- Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal DiseasesCompletedNCT04008771Not applicable
- A New Treatment of Retinitis PigmentosaStatus unknownNCT03998384Not applicable
- Retrospective Natural History Study of Retinitis PigmentosaStatus unknownNCT03975543
- Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic MutationActive, not recruitingNCT03963154Phase 1/2
- Prospective Open Clinical and Genetic Study of Patients With Retinitis PigmentosaCompletedNCT03901391
- Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A GeneCompletedNCT03780257Phase 1/2
- Stem Cells Therapy in Degenerative Diseases of the RetinaStatus unknownNCT03772938Phase 1
- Ocular Manifestations in Rheumatic DiseasesCompletedNCT03753893
- Experimental and Clinical Studies of Retinal StimulationStatus unknownNCT03635645Not applicable
- RETINA IMPLANT Alpha AMS in Blind Patients With Retinitis PigmentosaWithdrawnNCT03629899Not applicable
- Development of Visual Function Evaluation Method (2)CompletedNCT03626207
- Treatment of RP and LCA by Primary RPE TransplantationStatus unknownNCT03566147Early Phase 1
- Argus II Retinal Prosthesis System - Better Vision RP StudyWithdrawnNCT03418116Not applicable
- Study of a Suprachoroidal Retinal ProsthesisCompletedNCT03406416Not applicable
- Exercise and RP (AVAMC and Emory)CompletedNCT03381235Not applicable
- Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis PigmentosaCompletedNCT03368027Not applicable
- Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)CompletedNCT03349242
- Clinical and Genetic Testing of Patients With Usher SyndromeCompletedNCT03319524
- Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR MutationsActive, not recruitingNCT03316560Phase 1/2
- Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)CompletedNCT03314207
- Development of Visual Function Evaluation MethodCompletedNCT03281005
- Argus II/ORCAM Device StudyCompletedNCT03248388Not applicable
- The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa PatientsStatus unknownNCT03078309Early Phase 1
- The FIGHT-RP1 StudyCompletedNCT03063021Phase 1
- Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)TerminatedNCT02926092
- Studying a Potential Protective Effect of L-Dopa on Retinitis PigmentosaStatus unknownNCT02837640Phase 2
- Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective StudyStatus unknownNCT02804360Phase 2
- Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy TrialCompletedNCT02759952
- Safety and Efficacy of the Alpha AMS Subretinal ImplantCompletedNCT02720640Not applicable
- Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis PigmentosaStatus unknownNCT02709876Phase 1/2
- Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal DystrophyCompletedNCT02670980Not applicable
- Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular EdemaCompletedNCT02609165Phase 2
- PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMSWithdrawnNCT02588430
- Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRATCompletedNCT02575430
- Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter StudyWithdrawnNCT02548572Not applicable
- Safety and Tolerability of hRPC in Retinitis PigmentosaActive, not recruitingNCT02464436Phase 1/2
- Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied DiseasesStatus unknownNCT02309866
- Post-Market Study of the Argus® II Retinal Prosthesis System - FranceCompletedNCT02303288
- Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis PigmentosaCompletedNCT02280135Phase 1
- Observational Study of the Argus® II Retinal Prosthesis SystemStatus unknownNCT01999049
- Biomarkers In Retinitis Pigmentosa (BIRP)CompletedNCT01949623
- Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis PigmentosaStatus unknownNCT01914913Phase 1/2
- Visual and Functional Assessment in Low Vision PatientsCompletedNCT01876147
- Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal DystrophyCompletedNCT01864486Not applicable
- New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis SystemTerminatedNCT01860092
- TES for the Treatment of RPCompletedNCT01847365Not applicable
- Transcorneal Electrical Stimulation - Multicenter Safety StudyCompletedNCT01835002Not applicable
- Microcurrent Stimulation to Treat Macular DegenerationCompletedNCT01790958
- Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis PigmentosaTerminatedNCT01786395Phase 3
- The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella BardawilActive, not recruitingNCT01680510Phase 1/2
- Acupuncture for the Treatment of Vision Loss Due to Retinitis PigmentosaCompletedNCT01604356Phase 1
- Pilot Study of a Suprachoroidal Retinal ProsthesisCompletedNCT01603576Not applicable
- Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis PigmentosaCompletedNCT01560715Phase 2
- Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)CompletedNCT01543906Phase 1
- Intravitreal Injection of MSCs in Retinitis PigmentosaCompletedNCT01531348Phase 1
- Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)CompletedNCT01521793Phase 1
- Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind PatientsCompletedNCT01497379Not applicable
- Argus® II Retinal Prosthesis System Post-Market Surveillance StudyTerminatedNCT01490827
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
- Efficacy and Safety of Oral Valproic Acid for Retinitis PigmentosaCompletedNCT01399515Phase 2
- The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis PigmentosaCompletedNCT01256697Not applicable
- Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / GenesCompletedNCT01235624Not applicable
- Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind PatientsCompletedNCT01024803Not applicable
- Evaluation of Objective Perimetry Using PupillometerCompletedNCT01021982
- Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) MutationsCompletedNCT01014052Phase 1
- Transcorneal Electrical Stimulation Therapy for Retinal DiseaseCompletedNCT00804102Not applicable
- Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis PigmemtosaCompletedNCT00784901
- The Role of Capsular Tension Ring (CTR) in Anterior Capsular ContractionCompletedNCT00717080Phase 4
- Potential Research Participants for Future Studies of Inherited Eye DiseasesCompletedNCT00559234
- Stem Cell Transplantation in Ocular Lesions of Behcet's DiseaseTerminatedNCT00550498Phase 1
- Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptorsCompletedNCT00515814Not applicable
- Stress and Vision Fluctuations in Retinitis PigmentosaCompletedNCT00475254
- Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis PigmentosaCompletedNCT00461435Not applicable
- A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis PigmentosaTerminatedNCT00458575Phase 1
- Autoimmunity in Retinitis PigmentosaStatus unknownNCT00433277Not applicable
- IRIS PILOT - Extended Pilot Study With a Retinal Implant SystemStatus unknownNCT00427180Not applicable
- Safety Study in Retinal Transplantation for Retinitis Pigmentosa.CompletedNCT00345917Phase 2
- The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus RetinitisCompletedNCT00341172
- Molecular Genetics of Retinal DegenerationsCompletedNCT00231010
- Natural History and Genetic Studies of Usher SyndromeCompletedNCT00106743
- Efficacy of Elevated CD4 Counts on CMV RetinitisCompletedNCT00091884
- Investigating the Effect of Vitamin A Supplementation on Retinitis PigmentosaCompletedNCT00065455Phase 1
- Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the EyeCompletedNCT00063765Phase 1
- Effects of Lutein in Retinitis PigmentosaCompletedNCT00029289Phase 1/2
- Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by InjectionStatus unknownNCT00017784Phase 3
- A Genetic Analysis of Usher Syndrome in Ashkenazi JewsCompletedNCT00016471
- A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) InfectionCompletedNCT00005572
- Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis PigmentosaCompletedNCT00004827Not applicable
- Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus RetinitisCompletedNCT00004794Phase 2
- Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher SyndromeTerminatedNCT00004345
- The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSCompletedNCT00002437Phase 2
- A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSCompletedNCT00002432Not applicable
- A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSStatus unknownNCT00002384Not applicable
- The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the EyesCompletedNCT00002356Phase 2
- A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the EyesCompletedNCT00002355Not applicable